Pasithea Therapeutics Corp(KTTA)
$0.48-0.00 (-0.62%)
KTTA
Pasithea Therapeutics Corp financials statements
$0.48
At close:-0.00 (-0.62%)
Pasithea Therapeutics Corp (KTTA) Income Statement
153 Followers
Pasithea Therapeutics Corp Income Statement
Last quarter (Q3 2026), Pasithea Therapeutics Corp's total revenue was $0.00. In Q3, Pasithea Therapeutics Corp's net income was $-6.58M. See Pasithea Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 15.06K | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ -5.09K | $ -2.21K | |
| $ 20.86M | $ 14.25M | $ 15.98M | $ 12.58M | $ 4.51M | |
| Depreciation and Amortization | $ 662.59K | $ 649.03K | $ 648.45K | $ 5.09K | $ 1.38K |
| $ -20.19M | $ -13.60M | $ -15.33M | $ -11.72M | $ -2.17M | |
| $ -20.86M | $ -14.25M | $ -15.98M | $ -12.59M | $ -4.51M | |
| $ 429.61K | $ 345.38K | $ 471.61K | $ 861.09K | $ 2.33M | |
| $ -20.43M | $ -13.90M | $ -15.51M | $ -11.73M | $ -2.17M | |
| $ -20.43M | $ -13.90M | $ -15.96M | $ -13.94M | $ -2.17M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.91 | $ -12.69 | $ -13.01 | $ -10.34 | $ -4.20 |
| Diluted EPS | $ -2.91 | $ -12.69 | $ -13.01 | $ -10.34 | $ -4.20 |
| Weighted Average Shares Outstanding | 7.03M | 1.10M | 1.23M | 1.26M | 520.23K |
| Weighted Average Shares Outstanding (Diluted) | 7.03M | 1.10M | 1.23M | 1.26M | 520.23K |
Currency in USD
